NOTABLE LABS, LTD.

Analyst Reco. Notable Labs, Ltd.

Equities

NTBL

IL0012002452

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
0.9601 ^USD	-2.13%		-1.53%	-49.20%

Apr. 15	Chardan Cuts Price Target on Notable Labs to $7 From $9, Keeps Buy Rating	MT
Apr. 15	Chardan Cuts Price Target on Notable Labs to $7 From $9 on Higher Projected Future Share Count, Keeps Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chardan Cuts Price Target on Notable Labs to $7 From $9, Keeps Buy Rating	Apr. 15	MT
Chardan Cuts Price Target on Notable Labs to $7 From $9 on Higher Projected Future Share Count, Keeps Buy Rating	Apr. 15	MT
JMP Securities Cuts Notable Labs' Price Target to $9 From $13, Keeps Market Outperform Rating	Dec. 19	MT
Chardan Research Downgrades Vascular Biogenics to Neutral From Buy After OVAL Trial Fails to Meeting Enpoints	22-07-20	MT
Oppenheimer Downgrades Vascular Biogenics to Perform From Outperform, Removes $5.50 Price Target	22-07-20	MT
HC Wainwright Downgrades Vascular Biogenics to Neutral From Buy	22-07-20	MT
Chardan Capital Initiates Vascular Biogenics at Buy with $5 Price Target	22-04-28	MT
VASCULAR BIOGENICS : Chardan Suspends Coverage on Vascular Biogenics at Buy Rating With $5 Price Target	21-08-02	MT
VASCULAR BIOGENICS : Roth Capital Adjusts Vascular Biogenics PT to $7 From $5, Maintains Buy Rating	21-06-03	MT
VASCULAR BIOGENICS : Guggenheim Starts Vascular Biogenics at Buy With $7 Price Target	21-05-18	MT
VASCULAR BIOGENICS : HC Wainwright Adjusts Vascular Biogenics' Price Target to $4 from $3, Keeps Buy Rating	21-01-28	MT
VASCULAR BIOGENICS : Oppenheimer Adjusts Vascular Biogenics PT to $5 From $2.50, Maintains Outperform Rating	21-01-13	MT
VBL Presents Positive Interim Data from the OVAL Phase 3 Pivotal Study in Ovarian Cancer At the ASCO 20 Annual Meeting, Showing 58% or Higher Objective Response Rate	20-06-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer